Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5b777bbd6c-7sgmh Total loading time: 0 Render date: 2025-06-25T19:17:02.166Z Has data issue: false hasContentIssue false

Chapter 11 - The Common Ancestors of Anxiety and Depression: Comorbidity as a Cognitive, Behavioural, Neural and Cellular Phenotype, and Current Evidence for Photobiomodulation as a Novel Treatment

Published online by Cambridge University Press:  16 May 2024

By
Gabriel Barg ,
Julia N. Lukacs  and
Guillermo Perez Algorta
Edited by
Allan Young ,
Marsal Sanches ,
Jair C. Soares  and
Mario Juruena
Allan Young
Affiliation:
Institute of Psychiatry, King's College London
Marsal Sanches
Affiliation:
Baylor College of Medicine, Texas
Jair C. Soares
Affiliation:
McGovern Medical School, The University of Texas
Mario Juruena
Affiliation:
King's College London
Get access

Summary

The COVID-19 pandemic resurfaced and potentially exacerbated the issue of comorbidities in mental health, with anxiety and depression being a prominent example. The co-occurrence of these conditions may exceed 50%, while there is also an overlap in treatment options and challenges in treatment response. This is supported by evidence indicating similarities between mood and anxiety across multiple dimensions, including cognitive, behavioural, neurobiological, and intracellular mechanisms. Cognitive commonalities primarily refer to attentional and recollection biases towards threatening stimuli and negative information. Behavioural inhibition due to avoidance or reduced motivation is another similarity of anxiety and depression. Shared neurobiological mechanisms include amygdala hyper-reactivity and dysregulation of the HPA axis. At a cellular level, mitochondrial dysfunctions might be underlying stress response and the mechanisms responsible for stress adaptation and regulation. Novel therapeutics, such as photobiomodulation (PBM), have been informed by these mechanistic models.

Keywords

COVID-19depressionanxietycognitivebehaviouralneuralcellularphotobiomodulation (PBM)
Type
Chapter
Information
Clinical Textbook of Mood Disorders , pp. 116 - 124
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

McGinty, EE, Presskreischer, R, Han, H, Barry, CL. Psychological distress and loneliness reported by US adults in 2018 and April 2020. JAMA. 2020;324(1):93–4.CrossRefGoogle ScholarPubMed
Pierce, M, Hope, H, Ford, T, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiat. 2020;7(10):883–92.Google ScholarPubMed
Pan, K-Y, Kok, AAL, Eikelenboom, M, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiat. 2021;8(2):121–9.CrossRefGoogle ScholarPubMed
Kessler, RC, de Jonge, P, Shahly, V, et al. Epidemiology of depression. In Gotlib, IH and Hamman, CL, editors. Handbook of Depression. New York: Guilford Press, 2014; 7–24.Google Scholar
Kessler, RC, Berglund, P, Demler, O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.CrossRefGoogle ScholarPubMed
Kessler, RC, Berglund, P, Demler, O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.CrossRefGoogle ScholarPubMed
Rush, AJ, Warden, D, Wisniewski, SR, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23(8):627–47.Google Scholar
Bystritsky, A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11(9):805–14.CrossRefGoogle ScholarPubMed
Beck, AT, Brown, G, Steer, RA, Eidelson, JI, Riskind, JH. Differentiating anxiety and depression: a test of the cognitive content-specificity hypothesis. J Abnorm Psychol. 1987;96(3):179.CrossRefGoogle ScholarPubMed
Beck, AT. Depression Causes and Treatment. Philadelphia: University of Pennsylvania Press, 1972.Google Scholar
Williams, JMG. Cognitive Psychology and Emotional Disorders. 2nd ed. Chichester: Wiley, 1997; xii.Google Scholar
Bar-Haim, Y, Lamy, D, Pergamin, L, Bakermans-Kranenburg, MJ, Van Ijzendoorn, MH. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull. 2007;133(1):1.CrossRefGoogle ScholarPubMed
Armstrong, T, Olatunji, BO. Eye tracking of attention in the affective disorders: A meta-analytic review and synthesis. Clin Psychol Rev. 2012;32(8):704–23.CrossRefGoogle ScholarPubMed
Peckham, AD, McHugh, RK, Otto, MW. A meta‐analysis of the magnitude of biased attention in depression. Depress Anxiety. 2010;27(12):1135–42.CrossRefGoogle ScholarPubMed
NIMH. Supporting mental health during the COVID-19 pandemic 2020 Available from: www.nimh.nih.gov/news/science-news/2020/supporting-mental-health-during-the-covid-19-pandemic.Google Scholar
Duyser, F, van Eijndhoven, P, Bergman, M, et al. Negative memory bias as a transdiagnostic cognitive marker for depression symptom severity. J Affect Disord. 2020;274:1165–72.CrossRefGoogle ScholarPubMed
Mathersul, DC, Ruscio, AM. Forecasting the future, remembering the past: misrepresentations of daily emotional experience in generalized anxiety disorder and major depressive disorder. Cognit Ther Res. 2020;44(1):73–88.CrossRefGoogle Scholar
Barg, G, Carboni, A, Roche, T, Nin, V, Carretié, L. Evaluating the association of high trait anxiety with a bias in familiarity-based recognition of emotional stimuli. J Psychophysiol. 2020;34(3):179–91.CrossRefGoogle Scholar
Raes, F, Hermans, D, Williams, JMG, et al. Reduced autobiographical memory specificity and rumination in predicting the course of depression. J Abnorm Psychol. 2006;115(4):699.CrossRefGoogle ScholarPubMed
Eysenck, MW, Fajkowska, M. Anxiety and depression: toward overlapping and distinctive features. Cognit Emot. 2018;32(7):1391–400.CrossRefGoogle ScholarPubMed
McEvoy, PM, Watson, H, Watkins, ER, Nathan, P. The relationship between worry, rumination, and comorbidity: evidence for repetitive negative thinking as a transdiagnostic construct. J Affect Disord. 2013;151(1):313–20.CrossRefGoogle ScholarPubMed
Clark, LA, Watson, D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100(3):316–36.CrossRefGoogle ScholarPubMed
Watson, D. Differentiating the mood and anxiety disorders: a quadripartite model. Annu Rev Clin Psychol. 2009;5:221–47.CrossRefGoogle ScholarPubMed
Gray, J, McNaughton, N. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septohippocampal System. 2nd ed: Oxford: Oxford University Press, 2003.CrossRefGoogle Scholar
Davidson, RJ, Ekman, P, Saron, CD, Senulis, JA, Friesen, WV. Approach-withdrawal and cerebral asymmetry: emotional expression and brain physiology: I. J Pers Soc Psychol. 1990;58(2):330.CrossRefGoogle Scholar
Winer, ES, Salem, T. Reward devaluation: dot-probe meta-analytic evidence of avoidance of positive information in depressed persons. Psychol Bull. 2016;142(1):18.CrossRefGoogle ScholarPubMed
Larson, CL, Nitschke, JB, Davidson, RJ. Common and distinct patterns of affective response in dimensions of anxiety and depression. Emotion (Washington, DC). 2007;7(1):182.CrossRefGoogle ScholarPubMed
Zeytinoglu, S, Morales, S, Lorenzo, NE, et al. A developmental pathway from early behavioral inhibition to young adults’ anxiety during the COVID-19 pandemic. J Am Acad Child Adolesc Psychiatry. 2021;60(10):1300–8.CrossRefGoogle Scholar
Folk, JB, Zeman, JL, Poon, JA, Dallaire, DH. A longitudinal examination of emotion regulation: pathways to anxiety and depressive symptoms in urban minority youth. Child Adolesc Ment Health. 2014;19(4):243–50.CrossRefGoogle ScholarPubMed
Sandi, C, Richter-Levin, G. From high anxiety trait to depression: a neurocognitive hypothesis. Trends Neurosci. 2009;32(6):312–20.CrossRefGoogle ScholarPubMed
Rodrigues, SM, LeDoux, JE, Sapolsky, RM. The influence of stress hormones on fear circuitry. Annu Rev Neurosci. 2009;32:289–313.CrossRefGoogle ScholarPubMed
Janiri, D, Moser, DA, Doucet, GE, et al. Shared neural phenotypes for mood and anxiety disorders: a meta-analysis of 226 task-related functional imaging studies. JAMA Psychiatry. 2020;77(2):172–9.CrossRefGoogle ScholarPubMed
Chorpita, BF, Barlow, DH. The development of anxiety: the role of control in the early environment. Psychol Bull. 1998;124(1):3–21.CrossRefGoogle ScholarPubMed
Ravaldi, C, Ricca, V, Wilson, A, Homer, C, Vannacci, A. Previous psychopathology predicted severe COVID-19 concern, anxiety, and PTSD symptoms in pregnant women during “lockdown” in Italy. Arch Womens Ment Health. 2020;26(6):783–6.Google Scholar
Fountoulakis, KN, Apostolidou, MK, Atsiova, MB, et al. Self-reported changes in anxiety, depression and suicidality during the COVID-19 lockdown in Greece. J Affect Disord. 2021;279:624–9.CrossRefGoogle ScholarPubMed
Weger, M, Sandi, C. High anxiety trait: a vulnerable phenotype for stress-induced depression. Neurosci Biobehav Rev. 2018;87:27–37.CrossRefGoogle ScholarPubMed
Savage, JE, Sawyers, C, Roberson‐Nay, R, Hettema, JM. The genetics of anxiety‐related negative valence system traits. Am J Med Genet B Neuropsychiatr Genet. 2017;174(2):156–77.CrossRefGoogle ScholarPubMed
Kalia, M. Neurobiological basis of depression: an update. Metabolism. 2005;54(5):24–7.CrossRefGoogle ScholarPubMed
Manji, HK, Drevets, WC, Charney, DS. The cellular neurobiology of depression. Nature Med. 2001;7(5):541–7.CrossRefGoogle ScholarPubMed
Einat, H, Yuan, P, Manji, HK. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res. 2005;165(2):172–80.CrossRefGoogle ScholarPubMed
Burroughs, S, French, D. Depression and anxiety: role of mitochondria. Curr Anaesth Crit Care. 2007;18(1):34–41.CrossRefGoogle Scholar
Devane, CL, Chiao, E, Franklin, M, Kruep, EJ. Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. Am J Manag Care. 2005;11(12 Suppl):S344–53.Google ScholarPubMed
Zhang, L, Zhou, R, Li, X, Ursano, RJ, Li, H. Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med Hypotheses. 2006;66(6):1205–8.CrossRefGoogle ScholarPubMed
Dwivedi, Y, Rizavi, HS, Pandey, GN. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience. 2006;139(3):1017–29.CrossRefGoogle ScholarPubMed
Duchen, MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med. 2004;25(4):365–451.CrossRefGoogle ScholarPubMed
Filiou, MD, Sandi, C. Anxiety and brain mitochondria: a bidirectional crosstalk. Trends Neurosci. 2019;42(9):573–88.CrossRefGoogle ScholarPubMed
Allen, J, Romay-Tallon, R, Brymer, KJ, Caruncho, HJ, Kalynchuk, LE. Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front Neurosci-Switz. 2018;12:386.CrossRefGoogle ScholarPubMed
Shankman, SA, Gorka, SM, Katz, AC, et al. Side effects to antidepressant treatment in patients with depression and comorbid panic disorder. J Clin Psychiatry. 2017;78(4):433–40.CrossRefGoogle ScholarPubMed
Lanzafame, R. Light dosing and tissue penetration: it is complicated. Photobiomodul Photomed Laser Surg. 2020;38(7):393–4.Google ScholarPubMed
Caldieraro, MA, Cassano, P. Transcranial and systemic photobiomodulation for major depressive disorder: a systematic review of efficacy, tolerability and biological mechanisms. J Affect Disord. 2019;243:262–73.CrossRefGoogle ScholarPubMed
de Freitas, LF, Hamblin, MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):348–64.CrossRefGoogle ScholarPubMed
Karu, TI. Mitochondrial signaling in mammalian cells activated by red and near‐IR radiation. Photochem Photobiol. 2008;84(5):1091–9.CrossRefGoogle ScholarPubMed
Sommer, AP. Revisiting the photon/cell interaction mechanism in low-level light therapy. Photobiomodul Photomed Laser Surg. 2019;37(6):336–41.Google ScholarPubMed
Salehpour, F, Gholipour-Khalili, S, Farajdokht, F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review. Rev Neurosci. 2020;31(3):269–86.CrossRefGoogle ScholarPubMed
Chung, H, Dai, T, Sharma, SK, et al. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516–33.CrossRefGoogle ScholarPubMed
Askalsky, P, Iosifescu, DV. Transcranial photobiomodulation for the management of depression: current perspectives. Neuropsych Dis Treat. 2019;15:3255–72.CrossRefGoogle ScholarPubMed
Wu, X, Alberico, SL, Moges, H, et al. Pulsed light irradiation improves behavioral outcome in a rat model of chronic mild stress. Lasers Surg Med. 2012;44(3):227–32.CrossRefGoogle Scholar
Salehpour, F, Rasta, SH, Mohaddes, G, Sadigh‐Eteghad, S, Salarirad, S. Therapeutic effects of 10‐HzPulsed wave lasers in rat depression model: a comparison between near‐infrared and red wavelengths. Lasers Surg Med. 2016;48(7):695–705.CrossRefGoogle Scholar
Eshaghi, E, Sadigh‐Eteghad, S, Mohaddes, G, Rasta, SH. Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: a study of three different doses of 810 nm laser. Lasers Surg Med. 2019;51(7):634–42.CrossRefGoogle ScholarPubMed
Schiffer, F, Johnston, AL, Ravichandran, C, et al. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct. 2009;5:46.CrossRefGoogle Scholar
Disner, SG, Beevers, CG, Gonzalez-Lima, F. Transcranial laser stimulation as neuroenhancement for attention bias modification in adults with elevated depression symptoms. Brain Stimul. 2016;9(5):780–7.CrossRefGoogle ScholarPubMed
Cassano, P, Petrie, SR, Mischoulon, D, et al. Transcranial photobiomodulation for the treatment of major depressive disorder. The ELATED-2 Pilot Trial. Photomed Laser Surg. 2018;36(12):634–46.CrossRefGoogle ScholarPubMed
Quah-Smith, JI, Tang, WM, Russell, J. Laser acupuncture for mild to moderate depression in a primary care setting – a randomised controlled trial. Acupunct Med. 2005;23(3):103–11.CrossRefGoogle Scholar
Quah-Smith, I, Smith, C, Crawford, JD, Russell, J. Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention. J Affect Disord. 2013;148(2–3):179–87.CrossRefGoogle ScholarPubMed
Kartelishev, AV, Kolupaev, GP, Vernekina, NS, et al. [Laser technologies used in the complex treatment of psychopharmacotherapy resistant endogenic depression]. Voen Med Zh. 2004;325(11):37–42.Google ScholarPubMed
Kolupaev, GP, Kartelishev, AV, Vernekina, NS, Chebotkov, AA, Lakosina, ND. [Technologies of laser prophylaxis of depressive disorder relapses]. Voen Med Zh. 2007;328(2):31–4.Google ScholarPubMed
Caldieraro, MA, Sani, G, Bui, E, Cassano, P. Long-term near-infrared photobiomodulation for anxious depression complicated by Takotsubo cardiomyopathy. J Clin Psychopharmacol. 2018;38(3).CrossRefGoogle ScholarPubMed
Mannu, P, Saccaro, LF, Spera, V, Cassano, P. Transcranial photobiomodulation to augment lithium in bipolar-I disorder. Photobiomodul Photomed Laser Surg. 2019;37(10):577–8.Google ScholarPubMed
Hennessy, M, Hamblin, MR. Photobiomodulation and the brain: a new paradigm. J Opt. 2016;19(1):013003.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×